Clinical trials
Phase 2 Heart Failure trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
50 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2010 | 4 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 5 |
| 2014 | 2 |
| 2015 | 2 |
| 2017 | 4 |
| 2018 | 3 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 4 |
| 2024 | 3 |
| 2025 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 27 |
| Terminated | 11 |
| Recruiting | 6 |
| Active, not recruiting | 3 |
| Unknown status | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bayer | 5 |
| AstraZeneca | 4 |
| University of Alberta | 4 |
| Cardurion Pharmaceuticals, Inc. | 3 |
| University Health Network, Toronto | 3 |
| Bristol-Myers Squibb | 2 |
| Cytokinetics | 2 |
| Montreal Heart Institute | 2 |
| Pfizer | 2 |
| ARCA Biopharma, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Heart Failure | 50 |
| Cardiomyopathies | 3 |
| Cardiovascular Diseases | 3 |
| Diabetes Mellitus, Type 2 | 3 |
| Heart Diseases | 3 |
| Atrial Fibrillation | 2 |
| Atrial Flutter | 2 |
| Dyspnea | 2 |
| Heart Failure, Diastolic | 2 |
| Hypertension, Pulmonary | 2 |
Trials
Showing 1 to 25 of 50. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.